James Green

Translating the complexity of a world in motion into the intelligence you need.

JG
Editor
James Green

About This Column

James Green is a writer and strategist dedicated to finding the "signal in the noise" of modern progress. Building on a career spent deconstructing the high-stakes world of biotech and medical innovation, James now applies his forensic curiosity to the broader forces of change. He specializes in translating complex technological, market, and social shifts into clear, actionable insights. Whether he is analyzing a disruptive new industry, a shift in global investment, or the future of infrastructure, James provides the critical context needed to understand how today’s breakthroughs will reshape our world tomorrow.

Displaying items 161-180 of 818 in total

Array Technologies' Earnings: A Bellwether for Solar's High-Stakes Future

Read full article
Array Technologies' Earnings: A Bellwether for Solar's High-Stakes Future

Carmel's New Frontier: A High-Stakes Fusion of Global Capital and Coast

Read full article
Carmel's New Frontier: A High-Stakes Fusion of Global Capital and Coast

Signal in the Rubble: Abra Group’s Network Becomes a Humanitarian Lifeline

Read full article
Signal in the Rubble: Abra Group’s Network Becomes a Humanitarian Lifeline

Signal in the Steel: How a €10M Deal Keeps Germany’s Arteries Flowing

Read full article
Signal in the Steel: How a €10M Deal Keeps Germany’s Arteries Flowing

Safe Harbor Unveils Operational Blueprint for Cannabis Banking's Next Phase

Read full article
Safe Harbor Unveils Operational Blueprint for Cannabis Banking's Next Phase

Calibrant's New Hire Signals a Power Play for the Data Center Gold Rush

Read full article
Calibrant's New Hire Signals a Power Play for the Data Center Gold Rush

Honeywell's New Math: A Doubled EPS Hides a $600M Cash Flow Question

Read full article
Honeywell's New Math: A Doubled EPS Hides a $600M Cash Flow Question

The Signal in the Cell: Niagen's Leap from NAD+ Supplements to a Rare Disease Drug

Read full article
The Signal in the Cell: Niagen's Leap from NAD+ Supplements to a Rare Disease Drug

Beyond the Hype: A New Award Separates Real Enterprise AI from the Noise

Read full article
Beyond the Hype: A New Award Separates Real Enterprise AI from the Noise

Ipsos Signals AI Urgency With Strategic Transformation Chief Hire

Read full article
Ipsos Signals AI Urgency With Strategic Transformation Chief Hire

EnWave’s Signal in the Noise: A Key Deal and Leadership Shift in Food Tech

Read full article
EnWave’s Signal in the Noise: A Key Deal and Leadership Shift in Food Tech

ServiceTrade Bridges the ERP Gap, Aims to Redefine Contractor Scalability

Read full article
ServiceTrade Bridges the ERP Gap, Aims to Redefine Contractor Scalability

Kindred’s Quiet Conquest: Reshaping Atlantic Canada’s Home Care Market

Read full article
Kindred’s Quiet Conquest: Reshaping Atlantic Canada’s Home Care Market

A French Veteran Arrives: Movmedix Brings a Proven, Polarizing Ligament to the U.S.

Read full article
A French Veteran Arrives: Movmedix Brings a Proven, Polarizing Ligament to the U.S.

The Signal from Abu Dhabi: Mubadala's Play for Credit Dominance

Read full article
BriefGlance

From Digital Worlds to Brazilian Pitches: A New CSR Playbook Emerges

Read full article
From Digital Worlds to Brazilian Pitches: A New CSR Playbook Emerges

The Silent Hazard: Why Post-Storm Electrical Checks Are Non-Negotiable

Read full article
The Silent Hazard: Why Post-Storm Electrical Checks Are Non-Negotiable

America's 250th: A Birthday Party or a Battle for Its Soul?

Read full article
BriefGlance

Tasmania's Tin Giant Awakens: Stellar Redraws the Global Supply Map

Read full article
Tasmania's Tin Giant Awakens: Stellar Redraws the Global Supply Map

Beisen's AI Pivot: A Profitable Blueprint for the Future of HR Tech

Read full article
Beisen's AI Pivot: A Profitable Blueprint for the Future of HR Tech
UCID: 64